Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Multidisciplinary Healthcare|September 22, 2025
Clinical Research for Inherited Retinal Disease Related Pediatric Blindness: A Preliminary Descriptive Analysis Based on ClinicalTrials.govAhmed M Ashour, Maan H Harbi, Fahad S Alshehri, et al.
Medicine|September 10, 2024
Use and effectiveness of PCSK-9 inhibitors in heart diseases: A reviewNasser M Alorfi, Maan H Harbi, Maguy Saffouh El Hajj, et al.
Frontiers in Medicine|May 8, 2026
Tirzepatide vs. semaglutide for obesity, glycemic control, and cardiovascular outcomes: a narrative review of clinical trialsMaan H Harbi, Ahmad M Ashour, Nasser M Alorfi, et al.
International Journal of Molecular Sciences|July 9, 2022
Antithrombotic Effects of Fostamatinib in Combination with Conventional Antiplatelet DrugsMaan H Harbi, Christopher W Smith, Fawaz O Alenazy, et al.
Journal of Thrombosis and Haemostasis : JTH|October 14, 2022
The Btk inhibitor AB-95-LH34 potently inhibits atherosclerotic plaque-induced thrombus formation and platelet procoagulant activityChristopher W Smith, Maan H Harbi, Lourdes Garcia-Quintanilla, et al.
Medicine|June 17, 2025
Exploring the career aspirations and motivations of doctor of pharmacy students: A qualitative studySaad M Wali, Ahmed M Ashour, Nasser M Alorfi, et al.
Medicine|September 3, 2025
Assessing pharmacy staff practices and knowledge of off-label drug use in Ministry of Health Hospitals, Saudi Arabia: A cross-sectional studyMohammed A Alomary, Norah F Alshehri, Abdullah M Alzahrani, et al.
Medicine|February 28, 2025
Evaluation of healthcare professionals' knowledge of Alzheimer's disease in government hospitals and healthcare centers: A cross-sectional study in Jeddah, Saudi ArabiaYahya A Alzahrani, Maan H Harbi, Adel G Almalki, et al.
Medicine|August 19, 2025
Public knowledge and acceptance of genetic testing for disability-related diseases in pharmacies: A cross-sectional study from Saudi ArabiaNasser M Alorfi, Saad M Wali, Ahmed M Ashour, et al.
Journal of Thrombosis and Haemostasis : JTH|August 4, 2023
Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapyFawaz O Alenazy, Maan H Harbi, Dean P Kavanagh, et al.
Pageof 3